WGS
GeneDx Holdings Corp.
WGS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
WGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Strong |
WGS's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.
WGS PE Valuation
WGS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.
WGS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect WGS to return to profit, with revenue growing.
WGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | — |
| Q3 2026 | -$3.76 | -3518% |
| Q2 2026 | -$3.62 | -5271% |
| Q1 2026 | -$2.66 | -$1.27 |
| Q4 2025 | -$0.73 | +$1.21 |
| Q3 2025 | $0.11 | +$3.01 |
| Q2 2025 | $0.07 | +$4.30 |
| Q1 2025 | -$1.39 | +$3.58 |
| Q4 2024 | -$1.94 | +$5.29 |
WGS has swung to a loss: it lost $3.76 per share over the past year, after a profit the year before.
WGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $123.1M | +5.4% |
| Q2 2026 | $114.4M | +11% |
| Q1 2026 | $102.3M | +17% |
| Q4 2025 | $121M | +27% |
| Q3 2025 | $116.7M | +52% |
| Q2 2025 | $102.7M | +46% |
| Q1 2025 | $87.1M | +40% |
| Q4 2024 | $95.6M | +67% |
WGS's revenue has grown year over year for 11 quarters in a row: $123M last quarter, up 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.5% | -5.7 points |
| Q2 2026 | -15% | -24 points |
| Q1 2026 | -56% | -51 points |
| Q4 2025 | -12% | -21 points |
| Q3 2025 | -2.8% | +7.3 points |
| Q2 2025 | 8.7% | +24 points |
| Q1 2025 | -5.2% | +17 points |
| Q4 2024 | 9.2% | +54 points |
WGS's operating margin was −8.5% last quarter, down 5.7 points from the same quarter a year ago.
WGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.8M | -265% |
| Q2 2026 | -$39.1M | -586% |
| Q1 2026 | -$38.9M | -1059% |
| Q4 2025 | -$7.4M | -$1.2M |
| Q3 2025 | $9.6M | +$14.6M |
| Q2 2025 | $8.1M | +$13.9M |
| Q1 2025 | $4.1M | +$20.9M |
| Q4 2024 | -$6.2M | +$26M |
WGS has burned cash in almost every quarter: −$101M over the past year, against $15M the year before.
WGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +170K shares |
| 1 year | +3.8% | +1.1M shares |
| 3 years | +16% | +4.1M shares |
WGS has 30M diluted shares, up 3.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
WGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
WGS has more cash than debt.
WGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 14.6 | Oversold |
WGS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
WGS PE vs Healthcare Sector
| Metric | WGS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
WGS has no meaningful PE right now: it lost money over the past year.
WGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.5 | 22% below |
| 20 week MA | $72.7 | 29% below |
| 50 week MA | $79.8 | 35% below |
| 100 week MA | $89.1 | 42% below |
| 200 week MA | $54.0 | 4% below |
WGS is in a downtrend: it's below all five of its weekly moving averages, and 4% below its 200-week average.
WGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $323.4 | $382.5 | +18% |
| 2021 | $382.5 | $154.1 | -60% |
| 2022 | $154.1 | $8.02 | -95% |
| 2023 | $8.02 | $2.75 | -66% |
| 2024 | $2.75 | $78.1 | +2738% |
| 2025 | $78.1 | $133.8 | +71% |
| 2026 YTD | $133.8 | $51.9 | -61% |
WGS's yearly returns have swung widely, from +2738% in 2024 to −95% in 2022. It's down 61% so far in 2026.